AU2022265114A1 - Composition for stimulating immune cell metabolism - Google Patents

Composition for stimulating immune cell metabolism Download PDF

Info

Publication number
AU2022265114A1
AU2022265114A1 AU2022265114A AU2022265114A AU2022265114A1 AU 2022265114 A1 AU2022265114 A1 AU 2022265114A1 AU 2022265114 A AU2022265114 A AU 2022265114A AU 2022265114 A AU2022265114 A AU 2022265114A AU 2022265114 A1 AU2022265114 A1 AU 2022265114A1
Authority
AU
Australia
Prior art keywords
ergothioneine
composition
salt
present
immune cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022265114A
Other languages
English (en)
Inventor
Makoto Katsube
Mariko Ozawa
Hiroshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of AU2022265114A1 publication Critical patent/AU2022265114A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022265114A 2021-04-26 2022-03-25 Composition for stimulating immune cell metabolism Pending AU2022265114A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021074323 2021-04-26
JP2021-074323 2021-04-26
PCT/JP2022/014256 WO2022230494A1 (ja) 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物

Publications (1)

Publication Number Publication Date
AU2022265114A1 true AU2022265114A1 (en) 2023-10-12

Family

ID=83847368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022265114A Pending AU2022265114A1 (en) 2021-04-26 2022-03-25 Composition for stimulating immune cell metabolism

Country Status (7)

Country Link
US (1) US20240122899A1 (https=)
EP (1) EP4331582A4 (https=)
JP (1) JP7817249B2 (https=)
CN (1) CN117255683A (https=)
AU (1) AU2022265114A1 (https=)
TW (1) TW202308615A (https=)
WO (1) WO2022230494A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230000829A1 (en) * 2019-10-28 2023-01-05 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
JPWO2024172002A1 (https=) * 2023-02-16 2024-08-22
CN120640987A (zh) * 2023-02-16 2025-09-12 三得利控股株式会社 含有麦角硫因的更年期症状的预防或改善用组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103746A (en) 1997-02-20 2000-08-15 Oxis International, Inc. Methods and compositions for the protection of mitochondria
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
JP5088911B2 (ja) 2011-03-02 2012-12-05 国立大学法人北海道大学 抗微生物物質産生・分泌促進剤
CA2877861A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
JP6121597B1 (ja) 2016-06-09 2017-04-26 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびＴｈ１７細胞分化促進剤

Also Published As

Publication number Publication date
WO2022230494A1 (ja) 2022-11-03
TW202308615A (zh) 2023-03-01
CN117255683A (zh) 2023-12-19
EP4331582A4 (en) 2025-04-09
JPWO2022230494A1 (https=) 2022-11-03
JP7817249B2 (ja) 2026-02-18
EP4331582A1 (en) 2024-03-06
US20240122899A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
EP4331582A1 (en) Composition for stimulating immune cell metabolism
US20180021405A1 (en) Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
US20060029585A1 (en) Methods for reducing morbidity
AU2002311871A1 (en) Compositions for treating animal diseases and syndromes
US20240173298A1 (en) Composition for ameliorating or suppressing decline of kidney functions
EP4331680A1 (en) Composition for increasing leukocytes and/or basophils
US20240180876A1 (en) Composition for increasing red blood cells and/or hemoglobin
WO2024038821A1 (ja) フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物
US20240189284A1 (en) Composition for promoting lipolysis
HK40104910A (zh) 免疫细胞的代谢促进用组合物
US20240408052A1 (en) Composition containing sesamin and ergothioneine or salt thereof
US20250017905A1 (en) Composition for inhibiting histamine-n-methyltransferase
HK40103315A (zh) 白血球及/或嗜碱细胞增加用组合物
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
WO2024203675A1 (ja) エルゴチオネイン又はその塩を含有する熱中症又は脱水症を予防、軽減又は改善するための組成物及び細胞内外水分を調節するための組成物
HK40124129A (zh) 预防或改善衰弱用组合物，以及用於抑制或改善伴随年龄增长的身体活动能力下降的组合物
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
Brummer The influence of selenium status on immune function and antioxidant status in the horse